content top

Intravitreal Bevacizumab vs Sham Treatment in Acute Branch Retinal Vein Occlusion with Macular Edema: Short Term Results (Report 1)

Posted by , , , , , , , and on Oct 1, 2010 in Bevacizumab Avastin, Branch and hemicentral vein occlusion

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Siamak Moradian, Hooshang Faghihi, Babak Sadeghi, Niloofar Piri, Hamid Ahmadieh, Masoud Soheilian, Mohammad Hossein Dehghan, Mohsen Azarmina, Mohammad Riazi Esfahani (Tehran, Iran) Advantages: To compare the visual and anatomical (central macular thickness; CMT) outcomes of intravitreal bevacizumab (IVB) injections relative to sham...

Read More

Memantine in Acute Nonarteritic Anterior Ischemic Optic Neuropathy

Posted by , , , and on Oct 1, 2008 in Optic Neuropathy

M. Riazi Esfahani, Z Aalami, Gholami, AR Tabasi, A Mirshahi, M Movasat Advantages: To introduce the neuroprotective effect of Memantine (an NMDA type glutamatergic open-channel blocker) in visual functions of patients with acute NAION (Nonarteritic anterior ischemic optic neuropathy) and comparing it with placebo. Methods: Eligible eyes were randomly allocated to either Memantine tablets (5mg daily for first week and 10mg daily for the...

Read More
content top